
Repurposing a cholesterol drug may benefit DiGeorge syndrome patients with neuropsychiatric disease
Researchers have found that mitochondrial dysfunction in the blood-brain barrier (BBB) may lead to neuropsychiatric disease in some patients with DiGeorge syndrome.This article was originally published on MedicalXpress.com